GlassScriptPhysician profile
Sean Steenburgh
NPI 1134740293
$648.67
in general payments reported to CMS, 2019-2025
13 companies · $225 in 2025
The $225 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $140 · 2024: $284 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $631 · Education: $17.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $630.92 |
| Education | $17.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alafair Biosciences, INC. | $180.36 | 2024 | Versawrap |
| Curonix LLC | $149.98 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Treace Medical Concepts, INC. | $88.20 | 2023-2024 | |
| Urgo Medical North America, LLC | $51.35 | 2025 | Urgok2 |
| Orthofix Medical, INC. | $30.86 | 2023 | Physio-Stim |
| Depuy Synthes Sales INC. | $23.54 | 2025 | |
| Paragon 28, INC. | $20.07 | 2024 | Mtp |
| Stryker Corporation | $18.80 | 2023 | Augment Injectable |
| Horizon Therapeutics Plc | $17.78 | 2023 | Krystexxa |
| Bioventus LLC | $17.75 | 2023 | Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $17.64 | 2023 | Collagenase Santyl |
| Reprise Biomedical, INC. | $17.18 | 2024 | Miro3d |
| Integra Lifesciences Corporation | $15.16 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Steenburgh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.